Peter Thadani, MD
Orthopaedic Surgery · Munster, INNPI 1821128984
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.5%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. Medacta USA, Inc. accounts for 97.3% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $69,310 and has fallen 55.4% since, to $30,888 in 2025. Among orthopaedic surgery clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 187 payments — averaging $1690.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medacta USA, Inc.$307K
- Steris Corporation$6K
- Medwest Associates$1K
- Smith+Nephew$756
- Zimmer Biomet$288
- Johnson & Johnson$179
- plus $669 from 15 others
Across 6 payments — averaging $3470.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medacta USA, Inc.$21K
What the payments were for
- Royalty or licence$103,26133%
- Consulting fees$175,58656%
- Speaking & faculty fees$6,0002%
- Travel & lodging$26,0318%
- Food & beverage$4,0991%
- Education$1,2000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medacta USA, Inc. | 156 | $307,496 |
| Steris Corporation | 2 | $5,590 |
| Medwest Associates | 1 | $1,200 |
| Smith+Nephew | 8 | $756 |
| Zimmer Biomet | 2 | $288 |
| Johnson & Johnson | 2 | $179 |
| Bone Support Inc. | 2 | $173 |
| Terumo BCT, Inc. | 1 | $113 |
| Pacira Therapeutics, Inc. | 1 | $68 |
| Medical Device Business Services, Inc. | 1 | $55 |
| Pacira Pharmaceuticals Incorporated | 1 | $41 |
| Omnilife Science, Inc | 1 | $41 |
| Stryker | 1 | $39 |
| Ferring Pharmaceuticals Inc. | 1 | $23 |
| Vertex | 1 | $21 |
| KCI USA, Inc. | 1 | $21 |
| Davol Inc. | 1 | $17 |
| Intellijoint Surgical Inc. | 1 | $16 |
| Microport Orthopedics Inc | 1 | $16 |
| Globus Medical | 1 | $14 |
| Medtronic | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GMK SPHERE$103,805
- QUADRA$87,432
- AMISTEM$49,802
- Quadra C Femoral Stems$22,304
- GMK Sphere Revision System$11,883
- HarmonyAIR$11,120
- AMIStem H Femoral Stems$8,532
- HARMONY$5,560
- REAL INTELLIGENCE$558
- GMK REVISION$500
- Journey II$426
- Tandem$426
- REDAPT$426
- CERAMENTBONE VOID FILLER$137
- CERAMENT G$137
- NEXTAR$125
- Oxford$119
- Bone Marrow Aspirate Concentrate System$113
How this compares
$316,178 in reported general payments places this provider in the 95th percentile of 400 orthopaedic surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 135 | $475 |
| Oxycodone Hcl | 31 | $290 |
| Amoxicillin | 213 | $277 |
| Methylprednisolone | 37 | $244 |
| Gabapentin | 42 | $241 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $174 |
| Tramadol Hcl | 48 | $149 |
| Celecoxib | 14 | $125 |
| Cefadroxil | 12 | $82 |
| Clindamycin Hcl | 31 | $43 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Munster
- Mark ChangMunster$141K
- Frank KolisekGreenwood$7.5M
- David FisherIndianapolis$5.9M
- Michael BerendIndianapolis$4M
- John WilliamsFort Wayne$2.7M
- Sanford KunkelIndianapolis$1.9M
- Hill HastingsIndianapolis$1.6M
- Mark KlaassenElkhart$1.3M
- Alan McGeeFort Wayne$1.1M
- Lindsey RolstonNew Castle$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.